<?xml version="1.0" encoding="UTF-8"?>
<lom xmlns="http://ltsc.ieee.org/xsd/LOM" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://ltsc.ieee.org/xsd/LOM http://standards.ieee.org/reading/ieee/downloads/LOM/lomv1.0/xsd/lom.xsd">
<general>
<title>
<string language="el">Erk1/2 activation and modulation of STAT3 signaling in oral cancer</string>
</title>
<language>eng</language>
<identifier>
<catalog>URI</catalog>
<entry>http://hdl.handle.net/10795/1879</entry>
</identifier>
<subject>
<string language="el">ιατρικές επιστήμες</string>
<string language="el">οδοντιατρική</string>
<string language="el">καρκίνος</string>
<string language="el"></string>
</subject>
<description>
<string language="el">Constitutive activation of the signal transducer and activator of transcription 3 (STAT3) signaling pathway possesses confirmed oncogenic potential in oral squamous cell carcinoma (OSCC). Crosstalk with other molecular pathways contributes to STAT3 regulation in cancer. The effects of mitogen-activated protein kinases (MAPKs) and particularly extracellular signal-regulated kinase 1/2 (Erk1/2) on STAT3 signaling in OSCC have not been thoroughly investigated. The present study examined the effects of Erk1/2 modulation on STAT3 signaling and cell growth in OSCC cells. Constitutive expression levels of phosphorylated (tyrosine and serine) and total STAT3, Erk1/2 and cyclin D1 were assessed in OSCC cell lines. Erk1/2 modulation was achieved by pharmacological agents; siRNA silencing against Erk1/2 was also performed. Cell proliferation and viability were assessed. Erk1/2 inhibition with either U0126 treatment or specific siRNA silencing resulted in decreases in p-ser STAT3 and cyclin D1 levels and increases in p-tyr STAT3 in OSCC cells. Moreover, Erk1/2 inhibition resulted in a dose-dependent reduction in OSCC cell growth and viability. Erk1/2 induction had the opposite effects. Taken together, these results are supportive of an active crosstalk between the oncogenic Erk1/2 and STAT3 pathways in OSCC, the significance of which requires further investigation.</string>
</description>
<description>
<string language="el">8 pp.</string>
</description>
</general>
<lifecCycle>
<contribute>
<source>LOMv1.0</source>
<value>creator</value>
<entity><![CDATA[BEGIN:VCARD
FN: Gkouveris, I.
N: Gkouveris, I.
"VERSION:3.0"
END:VCARD]]></entity>
</contribute>
<contribute>
<source>LOMv1.0</source>
<value>Project Final Beneficiary</value>
<entity><![CDATA[BEGIN:VCARD
FN: Γκούβερης, Ιωάννης
N: Γκούβερης, Ιωάννης
"VERSION:3.0"
END:VCARD]]></entity>
</contribute>
<contribute>
<source>LOMv1.0</source>
<value>Project Executing Organisation</value>
<entity><![CDATA[BEGIN:VCARD
FN: Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Τμήμα Οδοντιατρικής. Εργαστήριο Στοματολογίας
N: Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Τμήμα Οδοντιατρικής. Εργαστήριο Στοματολογίας
"VERSION:3.0"
END:VCARD]]></entity>
</contribute>
<date>
<dateStamp>2014</dateStamp>
</date>
</lifecCycle>
<educational>
<learningResourceType>
<source>Digital Library of the Operational Programme "Education and Lifelong Learning" abstract types</source>
<value>Text</value>
</learningResourceType>
</educational><classification><keyword>
<string language="el">extracellular signal-regulated kinase 1/2</string>
</keyword>
<keyword>
<string language="el">signal transducer and activator of transcription 3 crosstalk</string>
</keyword>
<keyword>
<string language="el">cell signaling</string>
</keyword>
<keyword>
<string language="el">cell proliferation</string>
</keyword>
<keyword>
<string language="el">oral cancer</string>
</keyword>
</classification>
<technical>
</technical>
<technical>
<size>513676</size>
<format>application/pdf</format>
<location>http://repository.edulll.gr/edulll/bitstream/10795/1879/2/1879_Erk1-2%202014.pdf</location>
</technical>
<annotation></annotation><metaMetadata><identifier>
<catalog>URI</catalog>
<entry>http://hdl.handle.net/10795/1879</entry>
</identifier>
<contribute>
<entity><![CDATA[BEGIN:VCARD
FN:National Documentation Centre - National Hellenic Research Foundation
N:National Documentation Centre - National Hellenic Research Foundation
"VERSION:3.0"
END:VCARD]]></entity>
<role><source>LOMv1.0</source><value>creator</value></role>
<date><dateTime>2016-02-12T11:12:25Z</dateTime></date>
</contribute>
<contribute>
<entity><![CDATA[BEGIN:VCARD
FN:National Documentation Centre - National Hellenic Research Foundation
N:National Documentation Centre - National Hellenic Research Foundation
"VERSION:3.0"
END:VCARD]]></entity>
<role><source>LOMv1.0</source><value>validator</value></role>
<date><dateTime>2016-02-12T11:12:25Z</dateTime></date>
</contribute>
<metadataSchema>LOMv1.0</metadataSchema>
<language>gre</language>
</metaMetadata>
<rights>
<cost>no</cost>
<copyright>no</copyright>
<description>Copyright EYD-EPEDBM (Operational Programme "Education and Lifelong Learning")</description>
</rights>
</lom>